Rich Ulmer writes: “I’m now in work year number 55, split almost equally between pharmaceuticals (28 years at Allergan) and non-animal testing (26 years at InVitro International), with one year off for a delayed honeymoon. Today I am blessed to announce that InVitro’s second of three technologies has reached Global Harmonization System (GHS/OECD) regulatory adoption. This process took 10 years, 10 months, and 22 days to achieve at great time and expense. While awaiting this blessing, however, the number of animals saved from testing via our unregulated technologies reached (during 30+ years) the millions. InVitro International (OTC Market/IVRO) is publicly owned and one of only three companies in the world with a business model to research, develop, and market globally in vitro test methods which reduce/replace testing on animals. The U.S. is currently eight years behind Europe in legislating out of practice tests performed on animals when a regulatory approved in vitro test exists. Our population of 325 million or more in 90+ million households must become more award of this national tardiness. It’s both sad and a disgrace in my opinion.”
See more notes:
Class of 1964